Learn More About Vascular Genesis
Vascular Genesis
Reports Graph
Vascular Genesis is building a vascular regeneration platform with its line of cell-free, synthetic scaffold products, eliminating the need for tissue donation, immune suppressants, and the ever-present risk of transplant rejection. Our first product offering is a resorbable arteriovenous (AV) graft for dialysis access. The graft will degrade over a scheduled period of time and allow the body to create a new native tissue fistula for continual dialysis access. The graft is designed to match the compliance of the native artery/vein to which it attaches. Its self-healing capabilities will allow it to achieve stasis (stop bleeding) faster than competing products.
Technology/product details
Potential acquirers
Revenue projections
Capital raised to date
Growth strategy
Market landscape
CEO presentation
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next